Ryan N. Olson

Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study

A. Ananthakrishnan, C. J. van der Woude, N. Borren, 2020, Digestive Diseases and Sciences.

The impact of eculizumab on routine complement assays.

D. Murray, M. Snyder, F. Fervenza, 2018, Journal of immunological methods.